NEXGEL, Inc. (NXGL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
NEXGEL, Inc. (NXGL) stock price & volume — 10-year historical chart
NEXGEL, Inc. (NXGL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
NEXGEL, Inc. (NXGL) competitors in Wound care and infection prevention — business model, growth, and fundamentals comparison
NEXGEL, Inc. (NXGL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NEXGEL, Inc. (NXGL) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 2.15M | 1.99M | 2.21M | 717K | 674K | 1.55M | 2.05M | 4.09M | 8.69M | 11.66M |
| Revenue Growth % | - | -7.43% | 11.09% | -67.6% | -6% | 130.12% | 32.04% | 99.66% | 112.47% | 73.38% |
| Cost of Goods Sold | 2.27M | 1.84M | 1.7M | 854K | 965K | 1.54M | 1.79M | 3.71M | 5.94M | 7.2M |
| COGS % of Revenue | 105.3% | 92.62% | 76.77% | 119.11% | 143.18% | 99.48% | 87.5% | 90.85% | 68.37% | - |
| Gross Profit | -114K▲ 0% | 147K▲ 228.9% | 514K▲ 249.7% | -137K▼ 126.7% | -291K▼ 112.4% | 8K▲ 102.7% | 256K▲ 3100.0% | 374K▲ 46.1% | 2.75M▲ 634.8% | 4.47M▲ 0% |
| Gross Margin % | -5.3% | 7.38% | 23.23% | -19.11% | -43.18% | 0.52% | 12.5% | 9.15% | 31.63% | 38.3% |
| Gross Profit Growth % | - | 228.95% | 249.66% | -126.65% | -112.41% | 102.75% | 3100% | 46.09% | 634.76% | - |
| Operating Expenses | 1.75M | 1.12M | 2.4M | 1.79M | 1.97M | 2.58M | 3.6M | 3.85M | 6.3M | 7.45M |
| OpEx % of Revenue | 81.32% | 56.02% | 108.54% | 249.23% | 292.14% | 166.22% | 175.98% | 94.18% | 72.54% | - |
| Selling, General & Admin | 1.75M | 1.12M | 2.4M | 0 | 1.97M | 2.4M | 2.82M | 3.4M | 5.91M | 7.21M |
| SG&A % of Revenue | 81.32% | 56.02% | 108.54% | - | 292.14% | 155.06% | 137.5% | 83.1% | 68.04% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 31K | 367K | 103K | 78K | 8K |
| R&D % of Revenue | - | - | - | - | - | 2% | 17.92% | 2.52% | 0.9% | - |
| Other Operating Expenses | 0 | 0 | 0 | 1.79M | 0 | 142K | 421K | 350K | 313K | 233K |
| Operating Income | -1.86M▲ 0% | -969K▲ 48.0% | -1.89M▼ 94.8% | -1.92M▼ 1.9% | -2.26M▼ 17.5% | -2.57M▼ 13.7% | -3.35M▼ 30.3% | -3.48M▼ 3.9% | -3.55M▼ 2.2% | -2.98M▲ 0% |
| Operating Margin % | -86.62% | -48.64% | -85.31% | -268.34% | -335.31% | -165.7% | -163.48% | -85.03% | -40.91% | -25.54% |
| Operating Income Growth % | - | 48.02% | -94.84% | -1.91% | -17.46% | -13.72% | -30.27% | -3.85% | -2.21% | - |
| EBITDA | -1.54M | -653K | -1.57M | -1.86M | -2.21M | -2.43M | -3.05M | -3.03M | -3.07M | -2.49M |
| EBITDA Margin % | -71.56% | -32.78% | -70.76% | -259% | -327.89% | -156.8% | -148.78% | -74.2% | -35.38% | -21.35% |
| EBITDA Growth % | - | 57.6% | -139.82% | -18.58% | -19.01% | -10.05% | -25.29% | 0.43% | -1.32% | 23.42% |
| D&A (Non-Cash Add-back) | 324K | 316K | 322K | 67K | 50K | 138K | 301K | 443K | 480K | 488K |
| EBIT | -1.86M | -969K | -1.89M | -1.92M | -2.25M | -2.31M | -3.41M | -3.17M | -3.38M | -2.72M |
| Net Interest Income | 0 | 0 | 0 | 0 | -10K | -2M | -1.34M | -15K | -81K | -68K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 10K | 2M | 1.34M | 15K | 81K | 68K |
| Other Income/Expense | 25K | 0 | 0 | 1K | -4K | -1.74M | -1.4M | 289K | 91K | 190K |
| Pretax Income | -1.84M▲ 0% | -969K▲ 47.3% | -1.89M▼ 94.8% | -1.92M▼ 1.9% | -2.26M▼ 17.7% | -4.31M▼ 90.4% | -4.75M▼ 10.1% | -3.19M▲ 32.8% | -3.46M▼ 8.6% | -2.79M▲ 0% |
| Pretax Margin % | -85.46% | -48.64% | -85.31% | -268.2% | -335.9% | -277.89% | -231.74% | -77.97% | -39.86% | -23.91% |
| Income Tax | -63K | -16K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6K |
| Effective Tax Rate % | 3.43% | 1.65% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -0.22% |
| Net Income | -1.78M▲ 0% | -953K▲ 46.3% | -1.89M▼ 98.1% | -1.92M▼ 1.9% | -2.26M▼ 17.7% | -4.31M▼ 90.4% | -4.75M▼ 10.1% | -3.16M▲ 33.5% | -3.28M▼ 3.9% | -2.88M▲ 0% |
| Net Margin % | -82.53% | -47.84% | -85.31% | -268.2% | -335.9% | -277.89% | -231.74% | -77.21% | -37.76% | -24.69% |
| Net Income Growth % | - | 46.34% | -98.11% | -1.85% | -17.73% | -90.37% | -10.12% | 33.48% | -3.93% | 18.39% |
| Net Income (Continuing) | -1.78M | -953K | -1.89M | -1.92M | -2.26M | -4.31M | -4.75M | -3.19M | -3.46M | -2.79M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 469K | 325K | 390K |
| EPS (Diluted) | -0.32▲ 0% | -0.17▲ 46.9% | -0.34▼ 100.0% | -0.35▼ 2.9% | -0.41▼ 17.1% | -0.77▼ 87.8% | -0.85▼ 10.4% | -0.56▲ 34.1% | -0.50▲ 10.7% | -0.36▲ 0% |
| EPS Growth % | - | 46.88% | -100% | -2.94% | -17.14% | -87.8% | -10.39% | 34.12% | 10.71% | 34.48% |
| EPS (Basic) | -0.32 | -0.17 | -0.34 | -0.35 | -0.41 | -0.77 | -0.85 | -0.56 | -0.50 | - |
| Diluted Shares Outstanding | 5.57M | 5.57M | 5.57M | 5.57M | 5.57M | 5.57M | 5.57M | 5.67M | 6.51M | 7.97M |
| Basic Shares Outstanding | 5.57M | 5.57M | 5.57M | 5.57M | 5.57M | 5.57M | 5.57M | 5.67M | 6.51M | 7.97M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
NEXGEL, Inc. (NXGL) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 257K | 199K | 361K | 513K | 363K | 13.93M | 7.5M | 5.05M | 5.11M | 5.6M |
| Cash & Short-Term Investments | 0 | 0 | 0 | 261K | 32K | 13.35M | 6.61M | 2.7M | 1.81M | 938K |
| Cash Only | 0 | 0 | 0 | 261K | 32K | 13.35M | 1.1M | 2.7M | 1.81M | 938K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 5.51M | 0 | 0 | 0 |
| Accounts Receivable | 74K | 99K | 34K | 102K | 73K | 209K | 222K | 633K | 933K | 839K |
| Days Sales Outstanding | 12.55 | 18.14 | 5.61 | 51.92 | 39.53 | 49.18 | 39.57 | 56.5 | 39.2 | 27 |
| Inventory | 158K | 93K | 101K | 113K | 233K | 291K | 502K | 1.32M | 1.75M | 2.02M |
| Days Inventory Outstanding | 25.45 | 18.4 | 21.7 | 48.3 | 88.13 | 68.84 | 102.25 | 129.59 | 107.6 | 94.29 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 109K | 336K | 577K | 1.81M |
| Total Non-Current Assets | 1M | 695K | 378K | 1.38M | 1.89M | 3.06M | 2.85M | 4.9M | 5.87M | 6.02M |
| Property, Plant & Equipment | 831K | 522K | 200K | 1.2M | 1.36M | 2.65M | 2.46M | 3.35M | 3.84M | 4.08M |
| Fixed Asset Turnover | 2.59x | 3.82x | 11.07x | 0.60x | 0.50x | 0.59x | 0.83x | 1.22x | 2.26x | 3.07x |
| Goodwill | 0 | 0 | 0 | 0 | 311K | 311K | 311K | 1.13M | 1.13M | 1.13M |
| Intangible Assets | 0 | 0 | 0 | 0 | 47K | 33K | 20K | 326K | 807K | 712K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 173K | 173K | 178K | 178K | 178K | 63K | 63K | 95K | 95K | 380K |
| Total Assets | 1.26M▲ 0% | 894K▼ 29.1% | 739K▼ 17.3% | 1.89M▲ 155.8% | 2.26M▲ 19.4% | 16.98M▲ 652.5% | 10.36M▼ 39.0% | 9.96M▼ 3.9% | 10.98M▲ 10.3% | 11.62M▲ 0% |
| Asset Turnover | 1.71x | 2.23x | 2.99x | 0.38x | 0.30x | 0.09x | 0.20x | 0.41x | 0.79x | 1.09x |
| Asset Growth % | - | -29.1% | -17.34% | 155.75% | 19.42% | 652.46% | -39.02% | -3.88% | 10.33% | 20.08% |
| Total Current Liabilities | 384K | 210K | 407K | 800K | 1.33M | 2.89M | 859K | 2.55M | 2.47M | 3.31M |
| Accounts Payable | 147K | 63K | 157K | 510K | 658K | 254K | 265K | 1.23M | 1.29M | 795K |
| Days Payables Outstanding | 23.68 | 12.46 | 33.73 | 217.97 | 248.88 | 60.08 | 53.98 | 121.14 | 79.39 | 55.69 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 216K | 2.05M | 15K | 325K | 97K | 99K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 38K | 54K | 0 | 20K | 179K | 825K |
| Other Current Liabilities | 66K | 27K | 142K | 69K | 170K | 272K | 316K | 677K | 606K | 1.88M |
| Current Ratio | 0.67x | 0.95x | 0.89x | 0.64x | 0.27x | 4.82x | 8.74x | 1.98x | 2.07x | 2.07x |
| Quick Ratio | 0.26x | 0.50x | 0.64x | 0.50x | 0.10x | 4.72x | 8.15x | 1.46x | 1.36x | 1.36x |
| Cash Conversion Cycle | 14.32 | 24.07 | -6.42 | -117.75 | -121.22 | 57.94 | 87.84 | 64.95 | 67.4 | 65.6 |
| Total Non-Current Liabilities | 83K | 59K | 51K | 710K | 854K | 2.01M | 1.86M | 2.24M | 2.43M | 2.74M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 256K | 266K | 268K | 513K | 588K | 515K |
| Capital Lease Obligations | 0 | 0 | 0 | 710K | 598K | 1.74M | 1.59M | 1.73M | 1.84M | 7.57M |
| Deferred Tax Liabilities | 16K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 83K | 59K | 51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 467K | 269K | 458K | 1.51M | 2.19M | 4.9M | 2.72M | 4.79M | 4.9M | 6.04M |
| Total Debt | 0 | 0 | 0 | 917K | 1.28M | 4.26M | 2.08M | 2.8M | 2.83M | 3.19M |
| Net Debt | 0 | 0 | 0 | 656K | 1.25M | -9.09M | 982K | 98K | 1.02M | 2.25M |
| Debt / Equity | - | - | - | 2.41x | 17.99x | 0.35x | 0.27x | 0.54x | 0.46x | 0.46x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -1.28x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.90x |
| Interest Coverage | - | - | - | - | -226.00x | -1.29x | -2.51x | -231.80x | -43.88x | -40.04x |
| Total Equity | 794K▲ 0% | 625K▼ 21.3% | 281K▼ 55.0% | 380K▲ 35.2% | 71K▼ 81.3% | 12.09M▲ 16921.1% | 7.64M▼ 36.8% | 5.17M▼ 32.4% | 6.08M▲ 17.7% | 5.58M▲ 0% |
| Equity Growth % | - | -21.28% | -55.04% | 35.23% | -81.32% | 16921.13% | -36.81% | -32.36% | 17.69% | 48.16% |
| Book Value per Share | 0.14 | 0.11 | 0.05 | 0.07 | 0.01 | 2.17 | 1.37 | 0.91 | 0.93 | 0.70 |
| Total Shareholders' Equity | 794K | 625K | 281K | 380K | 71K | 12.09M | 7.64M | 4.7M | 5.75M | 5.19M |
| Common Stock | 794K | 625K | 281K | 57K | 99K | 6K | 6K | 6K | 8K | 8K |
| Retained Earnings | 0 | 0 | 0 | -238K | -2.5M | -6.81M | -11.56M | -14.71M | -18M | -20.03M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 469K | 325K | 390K |
NEXGEL, Inc. (NXGL) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -1.32M | -777K | -1.54M | -1.81M | -1.8M | -2.75M | -2.99M | -3.24M | -3.87M | -3.87M |
| Operating CF Margin % | -61.2% | -39.01% | -69.77% | -253% | -267.21% | -177.5% | -146.09% | -79.14% | -44.51% | - |
| Operating CF Growth % | - | 41% | -98.71% | -17.49% | 0.72% | -52.86% | -8.68% | -8.16% | -19.5% | 94.33% |
| Net Income | -1.78M | -953K | -1.89M | -1.92M | -2.26M | -4.31M | -4.75M | -3.16M | -3.28M | -2.88M |
| Depreciation & Amortization | 324K | 316K | 322K | 67K | 50K | 113K | 301K | 443K | 478K | 487K |
| Stock-Based Compensation | 12K | 7K | 206K | 4K | 232K | 285K | 298K | 217K | 367K | 594K |
| Deferred Taxes | -63K | -16K | 0 | 0 | 2K | -225K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -9K | -8K | -14K | -1K | 2K | 1.98M | 1.39M | -318K | -260K | -9K |
| Working Capital Changes | 195K | -123K | 36K | 39K | 177K | -593K | -234K | -421K | -1.17M | -643K |
| Change in Receivables | 212K | -27K | 66K | -68K | 29K | -137K | -13K | -411K | -300K | 55K |
| Change in Inventory | 46K | 60K | -3K | -12K | -99K | -58K | -211K | -760K | -432K | -241K |
| Change in Payables | -35K | -84K | 94K | 203K | 137K | -405K | 11K | 968K | 182K | -289K |
| Cash from Investing | 0 | -7K | 0 | 0 | -312K | -269K | -5.59M | 4.46M | -775K | -91K |
| Capital Expenditures | 0 | -7K | 0 | 0 | -312K | -269K | -96K | -696K | -443K | -97K |
| CapEx % of Revenue | - | 0.35% | - | - | 46.29% | 17.34% | 4.69% | 17.02% | 5.1% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 96K | -547K | -400K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -96K | -500K | 0 | 0 |
| Cash from Financing | 1.32M | 784K | 1.54M | 2.08M | 1.88M | 16.34M | -3.66M | 379K | 3.75M | 3.34M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 514K | 2.98M | -3.66M | 379K | 218K | -152K |
| Equity Issued (Net) | 0 | 0 | 0 | 730K | 1.37M | 13.47M | 0 | 0 | 3.77M | 3.79M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.32M | 784K | 1.54M | 1.34M | 0 | -115K | 0 | 0 | -241K | -292K |
| Net Change in Cash | 0▲ 0% | 0▲ 0% | 0▲ 0% | 261K▲ 0% | -229K▼ 187.7% | 13.32M▲ 5915.7% | -12.25M▼ 192.0% | 1.6M▲ 113.1% | -893K▼ 155.8% | 799K▲ 0% |
| Free Cash Flow | -1.32M▲ 0% | -784K▲ 40.5% | -1.54M▼ 96.9% | -1.81M▼ 17.5% | -2.11M▼ 16.5% | -3.02M▼ 43.0% | -3.09M▼ 2.2% | -3.93M▼ 27.3% | -4.31M▼ 9.6% | -2.55M▲ 0% |
| FCF Margin % | -61.2% | -39.36% | -69.77% | -253% | -313.5% | -194.84% | -150.78% | -96.16% | -49.61% | -21.84% |
| FCF Growth % | - | 40.47% | -96.94% | -17.49% | -16.48% | -43.02% | -2.18% | -27.33% | -9.61% | 37.15% |
| FCF per Share | -0.24 | -0.14 | -0.28 | -0.33 | -0.38 | -0.54 | -0.55 | -0.69 | -0.66 | -0.66 |
| FCF Conversion (FCF/Net Income) | 0.74x | 0.82x | 0.82x | 0.94x | 0.80x | 0.64x | 0.63x | 1.03x | 1.18x | 0.88x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NEXGEL, Inc. (NXGL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -134.32% | -416.78% | -581.85% | -1003.99% | -70.91% | -48.13% | -49.32% | -58.35% | -51.71% |
| Return on Invested Capital (ROIC) | -102.43% | -312.58% | -219.13% | -144.13% | -89.34% | -43.23% | -37.57% | -43.12% | -43.12% |
| Gross Margin | 7.38% | 23.23% | -19.11% | -43.18% | 0.52% | 12.5% | 9.15% | 31.63% | 38.3% |
| Net Margin | -47.84% | -85.31% | -268.2% | -335.9% | -277.89% | -231.74% | -77.21% | -37.76% | -24.69% |
| Debt / Equity | - | - | 2.41x | 17.99x | 0.35x | 0.27x | 0.54x | 0.46x | 0.46x |
| Interest Coverage | - | - | - | -226.00x | -1.29x | -2.51x | -231.80x | -43.88x | -40.04x |
| FCF Conversion | 0.82x | 0.82x | 0.94x | 0.80x | 0.64x | 0.63x | 1.03x | 1.18x | 0.88x |
| Revenue Growth | -7.43% | 11.09% | -67.6% | -6% | 130.12% | 32.04% | 99.66% | 112.47% | 73.38% |
NEXGEL, Inc. (NXGL) stock FAQ — growth, dividends, profitability & financials explained
NEXGEL, Inc. (NXGL) reported $11.7M in revenue for fiscal year 2024. This represents a 442% increase from $2.2M in 2016.
NEXGEL, Inc. (NXGL) grew revenue by 112.5% over the past year. This is strong growth.
NEXGEL, Inc. (NXGL) reported a net loss of $2.9M for fiscal year 2024.
NEXGEL, Inc. (NXGL) has a return on equity (ROE) of -58.3%. Negative ROE indicates the company is unprofitable.
NEXGEL, Inc. (NXGL) had negative free cash flow of $2.5M in fiscal year 2024, likely due to heavy capital investments.
NEXGEL, Inc. (NXGL) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates